After months of pandemic-related deal delays, mergers and acquisitions (M&A) in the behavioral health industry are back on the rise. The third quarter of 2020 saw 26 deals, two more than in Q3 of 2019, according to data from Mertz Taggart. This resurgence reflects not only the strength of behavioral health as a sector but also investors’ renewed interest in opportunities that have proven resilient during COVID-19.
Experts predict that 2021 will not only start strong but maintain momentum throughout the year. In fact, industry leaders believe behavioral health M&A could outpace previous years, as demand for services and providers continues to climb.
Why The Pandemic Boosted Behavioral Health Deals
Although COVID-19 initially slowed activity, the pandemic ultimately made behavioral health even more attractive to investors. The need for mental health and substance use disorder (SUD) services has become urgent, with the Centers for Disease Control and Prevention (CDC) reporting that nearly 41% of U.S. adults experienced mental health or substance use struggles in June 2020.
As other health care sectors struggled with reduced patient volumes, elective procedure delays, and financial instability, behavioral health remained steady and even grew in importance. Burk Lindsey, managing director at Raymond James & Associates, noted that sectors less affected by COVID-19—such as home health, hospice, veterinary care, and behavioral health—are drawing heightened investor attention. In short, capital remains plentiful, but the number of strong targets has narrowed, creating a competitive environment for behavioral health deals.
The Numbers Behind Behavioral Health M&A
Behavioral health has been a consistently active sector for M&A in recent years. In 2018, the industry saw 97 deals, followed by 85 in 2019. The pandemic briefly slowed that pace in early 2020, but the rebound in Q3 demonstrates the sector’s resilience.
Scott Kremeier, director at Houlihan Lokey, pointed out that a flurry of deal launches occurred after Labor Day, many of which are expected to close in late Q4 2020 or early Q1 2021. While Q4 may not quite match the high deal volume of 2019, Q1 of 2021 is expected to exceed typical levels as postponed transactions are completed.
Telehealth Fuels Attractiveness Of Behavioral Health
One major reason behavioral health has remained attractive is its quick and effective pivot to telehealth. While many sectors of health care struggled to adapt to pandemic restrictions, behavioral health providers embraced virtual care and expanded access to patients nationwide.
Kevin Taggart, managing partner at Mertz Taggart, emphasized that this shift positions providers well for long-term growth. Demand for behavioral health services has increased alongside telehealth’s flexibility, creating an environment where providers can reach more patients while scaling operations. For investors, this creates strong opportunities for both initial acquisitions and follow-on deals.
Autism Treatment Remains A Prime Target
Among behavioral health subsectors, autism treatment continues to lead in deal volume. In Q3 2020, half of all completed behavioral health deals involved autism providers. The subsector’s consistent demand, growing patient base, and specialized nature make it particularly attractive to investors.
The emphasis on autism treatment reflects broader trends in health care investment, where niche specialties with high demand and scalable care models tend to attract strong interest. For families, this trend could mean greater access to treatment options and innovative approaches to care. For investors, it represents a stable opportunity in a competitive market.
Outpatient Mental Health Draws Strong Interest
Outpatient mental health also continues to be one of the most attractive areas for buyers. Mike Moran, principal at American HealthCare Capital, highlighted that outpatient mental health providers are not only in high demand but also highly profitable compared to other care settings.
The scalability of outpatient services, combined with the growing prevalence of mental health challenges during the pandemic, makes this subsector especially appealing. Moran noted that buyer interest in outpatient mental health is far from new but has only intensified in recent years. He expects this momentum to continue well into 2021 and beyond.
Investors Compete For Fewer Opportunities
The phrase “equal capital chasing fewer viable targets” has become a defining theme for 2021. With strong investor appetite and fewer high-quality behavioral health organizations available, competition for deals is fierce. This environment favors providers that have successfully adapted to new care models and demonstrated financial stability during COVID-19.
Behavioral health organizations that embraced telehealth, streamlined operations, and maintained patient volumes are now in an excellent position to attract buyers. For those considering a sale or partnership, the next year could be an opportune time to capitalize on heightened demand.
Long-Term Outlook For Behavioral Health M&A
Looking beyond 2021, experts agree that behavioral health will remain a hot sector for M&A. The combination of rising demand, scalable service models, and proven resilience during crises makes it an appealing long-term investment. Moran emphasized that while no one can predict the future with certainty, the industry’s momentum shows no signs of slowing down.
As the need for mental health and substance use treatment grows, the value of behavioral health providers will only increase. The pandemic has spotlighted the importance of accessible care, and investors are responding by putting their capital toward organizations that can meet this need.
What This Means For Providers And Patients
For providers, the current environment presents both challenges and opportunities. On one hand, competition among investors means that behavioral health organizations in strong financial standing can command favorable valuations. On the other hand, providers may face pressure to scale quickly, adopt new technologies, and demonstrate efficiency to remain competitive in the M&A landscape.
For patients, the increased investment in behavioral health is likely to improve access to care. Expanded telehealth capabilities, greater availability of outpatient services, and more specialized autism treatment options are all outcomes of this heightened investor focus. While consolidation raises questions about changes in ownership and care delivery, it also creates potential for improved resources and expanded service offerings.
Conclusion
After a brief slowdown in early 2020, behavioral health M&A has rebounded with strength, and experts predict a sizzling year ahead in 2021. With investor demand high and the number of viable targets limited, competition in the market is fierce. Behavioral health organizations that adapted successfully to the challenges of COVID-19, particularly through telehealth, are now positioned as some of the most attractive investment opportunities in health care.
Autism treatment and outpatient mental health remain leading subsectors for deals, reflecting strong patient demand and scalable models of care. Looking forward, the momentum in behavioral health M&A shows no signs of slowing, making it one of the most promising sectors in health care investment.
The combination of increased patient needs, innovative care delivery methods, and investor appetite ensures that behavioral health will remain a key focus well beyond 2021. For providers, this means opportunity for growth and investment, while for patients, it promises greater access to vital services at a time when they are needed most.
